Publication Month: Nov 2019 | Report Code: TIPRE00003530 | No. of Pages: 169 | Category: Medical Device | Status: Published
Surgical retractors are surgical instruments that are used by the doctor during the surgical procedure. The surgical retractors are also known as a surgical detractor. The retractor is a simple steel tool that has a curvy or angled blade at one end with a handle to hold it properly. Surgical retractors are used to separate the ends of surgical incision or wounds. Moreover, it is also used to keep the back of the tissue or organ. These instruments are used physically or by the robotic method in performing the surgical procedure. Apart from handheld, the surgical retractor is also available in self-retaining type. These instruments are available with different sizes, shapes, and styles in the market for various surgeries. The growth of the global surgical retractors market is attributed to increase in the number of surgical procedures and increase in the number of orthopaedic surgeries. However, rising demand of minimally invasive surgeries is the major factor hindering the market growth.
The global surgical retractors market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Get more information on this report :
Cardiovascular diseases or CVDs are likely to remain the prevalent cause of mortality and morbidity worldwide. The cardiovascular diseases are the disorders of the heart and blood vessels that include rheumatic heart disease, coronary heart disease, cerebrovascular disease, and other conditions. Some of the significant lifestyle factors which lead to cardiovascular disease and difficulties are the use of unhealthy diet, tobacco, and physical inactivity increases the risk of heart attacks and strokes. In contrast, the other risk factors for cardiovascular diseases are diabetes, increased level of cholesterol levels, and high blood pressure. The cardiovascular diseases are among the top ten leading causes of death across the world that affects majorly as compared to any other disease. As per the data provided by the World Health Organization, cardiovascular diseases are the number one cause of death across the world.
In Europe, the conditions and symptoms such as the rise in diabetic cases, lifestyle changes, and more are leading to an increasing number of cardiovascular surgeries, and general surgeries are the same. Since the last 25 years, in Europe and the European Union, the number of cardiovascular cases has increased. As per the data of WHO, cardiovascular diseases are the number one cause of death across the world. According to, European Cardiovascular Disease Statistics 2017, cardiovascular disease causes 3.9 million deaths every year and over 1.8 million deaths in the European Union (EU). The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the primary reason for the death of men and women in all countries. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults, who are around half of the US adult population, suffer from cardiovascular disease in the U.S.
Moreover, a large number of aesthetic, cosmetic, and plastic surgeries are done in the South and Central America due to the lower rates of the surgeries. Argentina possesses a high rank for plastic surgery, whereas, Venezuela is the popular destination for the buttocks or breast the centers as the plastic surgery centers are well specialize for implants and augmentation. Moreover, the South and Central American countries are known for medical tourism as the cost of the surgeries and medical facilities are cheaper as compared to the North American country, US. Along with cardiovascular surgeries, the aesthetic surgeries helps to upsurge the market for surgical retractors in the forecasted period.
In terms of product type, the global surgical retractors market is segmented into hand retractors, self-retaining retractors, wire retractors, and others. In 2018, the hand retractors segment held largest share of the market. However, the self-retaining retractors segment is estimated to register the highest CAGR during the forecast period.
Get more information on this report :
Based on application, the global surgical retractors market is segmented into obstetrics & gynecology, cardiovascular, neurosurgery, orthopedic surgery, reconstructive surgery, wound closure, and others. The obstetrics & gynecology segment held the largest market share in 2018. However, the reconstructive surgery segment is estimated to grow at the highest CAGR during the forecast period.
In terms of end user, the global surgical retractors market is segmented into hospitals, clinics, & surgical centers, ambulatory care centers, and maternity & fertility centers. The hospitals, clinics, & surgical centers segment held the largest share of the market in 2018. However, the maternity & fertility centers segment is estimated to grow at the highest CAGR during the forecast period.
|Market Size Value in||US$ 2,153.40 Million in 2018|
|Market Size Value by||US$ 3,724.46 Million by 2027|
|Growth rate||CAGR of 6.5% from 2019-2027|
|No. of Pages||169|
|No. of Tables||71|
|No. of Charts & Figures||67|
|Historical data available||Yes|
|Segments covered||Product Type ; Application ; End User , and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The global surgical retractors market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
The List of Companies